AA
ABBV icon

Aire Advisors’s AbbVie ABBV Stock Holding History

Aire Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Sell
1,784
-134
-7% -$28.8K 0.07% 118
2026
Q1 		$417K Buy
1,918
+103
+6% +$22.8K 0.08% 113
2025
Q4 		$415K Buy
1,815
+124
+7% +$28.2K 0.08% 108
2025
Q3 		$392K Sell
1,691
-311
-16% -$63.3K 0.07% 119
2025
Q2 		$372K Buy
2,002
+306
+18% +$56.9K 0.07% 118
2025
Q1 		$355K Sell
1,696
-829
-33% -$161K 0.07% 115
2024
Q4 		$449K Sell
2,525
-45
-2% -$8.27K 0.09% 112
2024
Q3 		$508K Buy
2,570
+15
+0.6% +$2.8K 0.11% 95
2024
Q2 		$438K Sell
2,555
-572
-18% -$94.8K 0.1% 99
2024
Q1 		$570K Sell
3,127
-168
-5% -$29K 0.13% 90
2023
Q4 		$511K Buy
3,295
+463
+16% +$67.5K 0.13% 89
2023
Q3 		$422K Buy
2,832
+17
+0.6% +$2.5K 0.11% 94
2023
Q2 		$379K Buy
2,815
+21
+0.8% +$3.08K 0.1% 95
2023
Q1 		$445K Sell
2,794
-50
-2% -$7.64K 0.12% 86
2022
Q4 		$455K Sell
2,844
-301
-10% -$46.2K 0.14% 85
2022
Q3 		$422K Buy
3,145
+257
+9% +$36.9K 0.15% 86
2022
Q2 		$443K Buy
2,888
+1,052
+57% +$161K 0.16% 81
2022
Q1 		$298K Buy
+1,836
New +$267K 0.11% 107

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aire Advisors's ABBV Position: Q2 2026 in Review

Aire Advisors reduced its AbbVie (ABBV) stake by 7% in Q2 2026, selling an estimated $28.8K and leaving 1,784 shares worth $449K. The position accounts for 0.07% of the portfolio, ranked #118.

Aire Advisors first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $570K in Q1 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aire Advisors held 1,784 shares of AbbVie worth $449K as of Q2 2026.
  • Aire Advisors sold 134 AbbVie shares in Q2 2026, an estimated $28.8K.
  • AbbVie made up 0.07% of Aire Advisors's portfolio in Q2 2026, its #118 holding.
  • Aire Advisors first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • Aire Advisors's AbbVie position peaked at $570K in Q1 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aire Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.